Overview
Cabaletta has been used in trials studying the treatment of Oculopharyngeal Muscular Dystrophy.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/10/23 | Phase 4 | Not yet recruiting | Southern California College of Optometry at Marshall B. Ketchum University | ||
2023/08/14 | Phase 4 | Not yet recruiting | |||
2022/10/28 | N/A | NO_LONGER_AVAILABLE | |||
2022/10/25 | Early Phase 1 | Recruiting | |||
2022/08/05 | Phase 2 | Terminated | |||
2022/05/02 | Phase 4 | UNKNOWN | Neuromed IRCCS | ||
2021/11/29 | Phase 2 | Completed | Merit E. Cudkowicz, MD | ||
2021/01/11 | Phase 4 | Completed | |||
2020/12/11 | Phase 1 | UNKNOWN | |||
2020/01/13 | Phase 2 | Withdrawn |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.